Industry Research Reports
Home > Reports > Chemical & Material > Oligonucleotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Oligonucleotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Industry: Chemical & Material
Published Date: 2026-07-14
Pages: 144 Pages
Report ld: 6925126
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Oligonucleotide Market Size(US$)
CAGR 2026-2032
10.1%
Market Size,2032
USD 3,237
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 1,817 million
Market Forecast in 2032(Value)
US$ 3,237 million
CAGR
10.1%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Oligonucleotide was estimated to be worth US$ 1666 million in 2025 and is projected to reach US$ 3237 million, growing at a CAGR of 10.1% from 2026 to 2032.
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.
Oligonucleotide drugs have the advantages of high therapeutic efficiency, low drug toxicity, and strong specificity, and have great potential in the treatment of metabolic diseases, genetic diseases, cancer, and prevention of infectious diseases. In recent years, due to the unique advantages of oligonucleotides in regulating gene expression, the research and development, production and commercialization of their drugs have developed rapidly, and the global market has continued to expand.
This report provides a comprehensive view of the global market for Oligonucleotide, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Oligonucleotide market size, estimations, and forecasts are presented in terms of sales volume (MT) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Oligonucleotide.
MARKET SEGMENTATION
By Company
- Abbott Molecular
- PerkinElmer
- SciGene Corporation
- Roche NimbleGen
- CytoTest
- Oligo Factory
- Danaher
- Thermo Fisher Scientific
- GE
- Merck
- Eurofins Scientific
- Agilent
- SUMITOMO CHEMICAL
- Bachem
- Sylentis
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- DNA
- RNA
Segment by Application
- Gene Chip
- Electrophoresis
- Fluorescence In Situ Hybridization
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Oligonucleotide manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Oligonucleotide sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Oligonucleotide sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Oligonucleotide Product Introduction
1.2 Global Oligonucleotide Market Size Forecast
1.2.1 Global Oligonucleotide Sales Value (2021–2032)
1.2.2 Global Oligonucleotide Sales Volume (2021–2032)
1.2.3 Global Oligonucleotide Sales Price (2021–2032)
1.3 Oligonucleotide Market Trends & Drivers
1.3.1 Oligonucleotide Industry Trends
1.3.2 Oligonucleotide Market Drivers & Opportunities
1.3.3 Oligonucleotide Market Challenges
1.3.4 Oligonucleotide Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Oligonucleotide Players Revenue Ranking (2025)
2.2 Global Oligonucleotide Revenue by Company (2021–2026)
2.3 Global Oligonucleotide Sales Volume Ranking of Players (2025)
2.4 Global Oligonucleotide Sales Volume by Company (2021–2026)
2.5 Global Oligonucleotide Average Price by Company (2021–2026)
2.6 Key Manufacturers Oligonucleotide Manufacturing Base and Headquarters
2.7 Key Manufacturers Oligonucleotide Product Offerings
2.8 Key Manufacturers Start of Mass Production of Oligonucleotide
2.9 Oligonucleotide Market Competitive Analysis
2.9.1 Oligonucleotide Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Oligonucleotide Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Oligonucleotide revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Oligonucleotide Market Classification
3.1 Introduction by Type
3.1.1 DNA
3.1.2 RNA
3.1.3 Global Oligonucleotide Sales Value by Type
3.1.3.1 Global Oligonucleotide Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global Oligonucleotide Sales Value, by Type (2021–2032)
3.1.3.3 Global Oligonucleotide Sales Value, by Type (%), 2021–2032
3.1.4 Global Oligonucleotide Sales Volume by Type
3.1.4.1 Global Oligonucleotide Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Oligonucleotide Sales Volume, by Type (2021–2032)
3.1.4.3 Global Oligonucleotide Sales Volume, by Type (%), 2021–2032
3.1.5 Global Oligonucleotide Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Gene Chip
4.1.2 Electrophoresis
4.1.3 Fluorescence In Situ Hybridization
4.2 Global Oligonucleotide Sales Value by Application
4.2.1 Global Oligonucleotide Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Oligonucleotide Sales Value, by Application (2021–2032)
4.2.3 Global Oligonucleotide Sales Value, by Application (%), 2021–2032
4.3 Global Oligonucleotide Sales Volume by Application
4.3.1 Global Oligonucleotide Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Oligonucleotide Sales Volume, by Application (2021–2032)
4.3.3 Global Oligonucleotide Sales Volume, by Application (%), 2021–2032
4.4 Global Oligonucleotide Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Oligonucleotide Sales Value by Region
5.1.1 Global Oligonucleotide Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Oligonucleotide Sales Value by Region (2021–2026)
5.1.3 Global Oligonucleotide Sales Value by Region (2027–2032)
5.1.4 Global Oligonucleotide Sales Value by Region (%), 2021–2032
5.2 Global Oligonucleotide Sales Volume by Region
5.2.1 Global Oligonucleotide Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Oligonucleotide Sales Volume by Region (2021–2026)
5.2.3 Global Oligonucleotide Sales Volume by Region (2027–2032)
5.2.4 Global Oligonucleotide Sales Volume by Region (%), 2021–2032
5.3 Global Oligonucleotide Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Oligonucleotide Sales Value, 2021–2032
5.4.2 North America Oligonucleotide Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Oligonucleotide Sales Value, 2021–2032
5.5.2 Europe Oligonucleotide Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Oligonucleotide Sales Value, 2021–2032
5.6.2 Asia Pacific Oligonucleotide Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Oligonucleotide Sales Value, 2021–2032
5.7.2 South America Oligonucleotide Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Oligonucleotide Sales Value, 2021–2032
5.8.2 Middle East & Africa Oligonucleotide Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Oligonucleotide Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Oligonucleotide Sales Value and Sales Volume
6.2.1 Key Countries/Regions Oligonucleotide Sales Value, 2021–2032
6.2.2 Key Countries/Regions Oligonucleotide Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Oligonucleotide Sales Value, 2021–2032
6.3.2 United States Oligonucleotide Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Oligonucleotide Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Oligonucleotide Sales Value, 2021–2032
6.4.2 Europe Oligonucleotide Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Oligonucleotide Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Oligonucleotide Sales Value, 2021–2032
6.5.2 China Oligonucleotide Sales Value by Type (%), 2025 vs 2032
6.5.3 China Oligonucleotide Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Oligonucleotide Sales Value, 2021–2032
6.6.2 Japan Oligonucleotide Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Oligonucleotide Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Oligonucleotide Sales Value, 2021–2032
6.7.2 South Korea Oligonucleotide Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Oligonucleotide Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Oligonucleotide Sales Value, 2021–2032
6.8.2 Southeast Asia Oligonucleotide Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Oligonucleotide Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Oligonucleotide Sales Value, 2021–2032
6.9.2 India Oligonucleotide Sales Value by Type (%), 2025 vs 2032
6.9.3 India Oligonucleotide Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Abbott Molecular
7.1.1 Abbott Molecular Company Information
7.1.2 Abbott Molecular Introduction and Business Overview
7.1.3 Abbott Molecular Oligonucleotide Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Abbott Molecular Oligonucleotide Product Offerings
7.1.5 Abbott Molecular Recent Developments
7.2 PerkinElmer
7.2.1 PerkinElmer Company Information
7.2.2 PerkinElmer Introduction and Business Overview
7.2.3 PerkinElmer Oligonucleotide Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 PerkinElmer Oligonucleotide Product Offerings
7.2.5 PerkinElmer Recent Developments
7.3 SciGene Corporation
7.3.1 SciGene Corporation Company Information
7.3.2 SciGene Corporation Introduction and Business Overview
7.3.3 SciGene Corporation Oligonucleotide Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 SciGene Corporation Oligonucleotide Product Offerings
7.3.5 SciGene Corporation Recent Developments
7.4 Roche NimbleGen
7.4.1 Roche NimbleGen Company Information
7.4.2 Roche NimbleGen Introduction and Business Overview
7.4.3 Roche NimbleGen Oligonucleotide Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Roche NimbleGen Oligonucleotide Product Offerings
7.4.5 Roche NimbleGen Recent Developments
7.5 CytoTest
7.5.1 CytoTest Company Information
7.5.2 CytoTest Introduction and Business Overview
7.5.3 CytoTest Oligonucleotide Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 CytoTest Oligonucleotide Product Offerings
7.5.5 CytoTest Recent Developments
7.6 Oligo Factory
7.6.1 Oligo Factory Company Information
7.6.2 Oligo Factory Introduction and Business Overview
7.6.3 Oligo Factory Oligonucleotide Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Oligo Factory Oligonucleotide Product Offerings
7.6.5 Oligo Factory Recent Developments
7.7 Danaher
7.7.1 Danaher Company Information
7.7.2 Danaher Introduction and Business Overview
7.7.3 Danaher Oligonucleotide Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Danaher Oligonucleotide Product Offerings
7.7.5 Danaher Recent Developments
7.8 Thermo Fisher Scientific
7.8.1 Thermo Fisher Scientific Company Information
7.8.2 Thermo Fisher Scientific Introduction and Business Overview
7.8.3 Thermo Fisher Scientific Oligonucleotide Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Thermo Fisher Scientific Oligonucleotide Product Offerings
7.8.5 Thermo Fisher Scientific Recent Developments
7.9 GE
7.9.1 GE Company Information
7.9.2 GE Introduction and Business Overview
7.9.3 GE Oligonucleotide Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 GE Oligonucleotide Product Offerings
7.9.5 GE Recent Developments
7.10 Merck
7.10.1 Merck Company Information
7.10.2 Merck Introduction and Business Overview
7.10.3 Merck Oligonucleotide Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Merck Oligonucleotide Product Offerings
7.10.5 Merck Recent Developments
7.11 Eurofins Scientific
7.11.1 Eurofins Scientific Company Information
7.11.2 Eurofins Scientific Introduction and Business Overview
7.11.3 Eurofins Scientific Oligonucleotide Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Eurofins Scientific Oligonucleotide Product Offerings
7.11.5 Eurofins Scientific Recent Developments
7.12 Agilent
7.12.1 Agilent Company Information
7.12.2 Agilent Introduction and Business Overview
7.12.3 Agilent Oligonucleotide Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 Agilent Oligonucleotide Product Offerings
7.12.5 Agilent Recent Developments
7.13 SUMITOMO CHEMICAL
7.13.1 SUMITOMO CHEMICAL Company Information
7.13.2 SUMITOMO CHEMICAL Introduction and Business Overview
7.13.3 SUMITOMO CHEMICAL Oligonucleotide Sales, Revenue, Price and Gross Margin (2021–2026)
7.13.4 SUMITOMO CHEMICAL Oligonucleotide Product Offerings
7.13.5 SUMITOMO CHEMICAL Recent Developments
7.14 Bachem
7.14.1 Bachem Company Information
7.14.2 Bachem Introduction and Business Overview
7.14.3 Bachem Oligonucleotide Sales, Revenue, Price and Gross Margin (2021–2026)
7.14.4 Bachem Oligonucleotide Product Offerings
7.14.5 Bachem Recent Developments
7.15 Sylentis
7.15.1 Sylentis Company Information
7.15.2 Sylentis Introduction and Business Overview
7.15.3 Sylentis Oligonucleotide Sales, Revenue, Price and Gross Margin (2021–2026)
7.15.4 Sylentis Oligonucleotide Product Offerings
7.15.5 Sylentis Recent Developments
8 Industry Chain Analysis
8.1 Oligonucleotide Industrial Chain
8.2 Oligonucleotide Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Oligonucleotide Sales Model
8.5.2 Sales Channels
8.5.3 Oligonucleotide Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Oligonucleotide Market Trends
Table 2. Oligonucleotide Market Drivers & Opportunities
Table 3. Oligonucleotide Market Challenges
Table 4. Oligonucleotide Market Restraints
Table 5. Global Oligonucleotide Revenue by Company (US$ Million), 2021–2026
Table 6. Global Oligonucleotide Revenue Market Share by Company (2021–2026)
Table 7. Global Oligonucleotide Sales Volume by Company (MT), 2021–2026
Table 8. Global Oligonucleotide Sales Volume Market Share by Company (2021–2026)
Table 9. Global Market Oligonucleotide Price by Company (USD/MT), 2021–2026
Table 10. Key Manufacturers Oligonucleotide Manufacturing Base and Headquarters
Table 11. Key Manufacturers Oligonucleotide Product Type
Table 12. Key Manufacturers Start of Mass Production of Oligonucleotide
Table 13. Global Oligonucleotide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Oligonucleotide revenue, 2025
Table 15. Mergers & Acquisitions and Expansion Plans
Table 16. Global Oligonucleotide Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 17. Global Oligonucleotide Sales Value by Type (US$ Million), 2021–2026
Table 18. Global Oligonucleotide Sales Value by Type (US$ Million), 2027–2032
Table 19. Global Oligonucleotide Sales Market Share in Value by Type (2021–2026)
Table 20. Global Oligonucleotide Sales Market Share in Value by Type (2027–2032)
Table 21. Global Oligonucleotide Sales Volume by Type: 2021 vs 2025 vs 2032 (MT)
Table 22. Global Oligonucleotide Sales Volume by Type (MT), 2021–2026
Table 23. Global Oligonucleotide Sales Volume by Type (MT), 2027–2032
Table 24. Global Oligonucleotide Sales Market Share in Volume by Type (2021–2026)
Table 25. Global Oligonucleotide Sales Market Share in Volume by Type (2027–2032)
Table 26. Global Oligonucleotide Price by Type (USD/MT), 2021–2026
Table 27. Global Oligonucleotide Price by Type (USD/MT), 2027–2032
Table 28. Global Oligonucleotide Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 29. Global Oligonucleotide Sales Value by Application (US$ Million), 2021–2026
Table 30. Global Oligonucleotide Sales Value by Application (US$ Million), 2027–2032
Table 31. Global Oligonucleotide Sales Market Share in Value by Application (2021–2026)
Table 32. Global Oligonucleotide Sales Market Share in Value by Application (2027–2032)
Table 33. Global Oligonucleotide Sales Volume by Application: 2021 vs 2025 vs 2032 (MT)
Table 34. Global Oligonucleotide Sales Volume by Application (MT), 2021–2026
Table 35. Global Oligonucleotide Sales Volume by Application (MT), 2027–2032
Table 36. Global Oligonucleotide Sales Market Share in Volume by Application (2021–2026)
Table 37. Global Oligonucleotide Sales Market Share in Volume by Application (2027–2032)
Table 38. Global Oligonucleotide Price by Application (USD/MT), 2021–2026
Table 39. Global Oligonucleotide Price by Application (USD/MT), 2027–2032
Table 40. Global Oligonucleotide Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 41. Global Oligonucleotide Sales Value by Region (US$ Million), 2021–2026
Table 42. Global Oligonucleotide Sales Value by Region (US$ Million), 2027–2032
Table 43. Global Oligonucleotide Sales Value by Region (%), 2021–2026
Table 44. Global Oligonucleotide Sales Value by Region (%), 2027–2032
Table 45. Global Oligonucleotide Sales Volume by Region (MT): 2021 vs 2025 vs 2032
Table 46. Global Oligonucleotide Sales Volume by Region (MT), 2021–2026
Table 47. Global Oligonucleotide Sales Volume by Region (MT), 2027–2032
Table 48. Global Oligonucleotide Sales Volume by Region (%), 2021–2026
Table 49. Global Oligonucleotide Sales Volume by Region (%), 2027–2032
Table 50. Global Oligonucleotide Average Price by Region (USD/MT), 2021–2026
Table 51. Global Oligonucleotide Average Price by Region (USD/MT), 2027–2032
Table 52. Key Countries/Regions Oligonucleotide Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 53. Key Countries/Regions Oligonucleotide Sales Value, (US$ Million), 2021–2026
Table 54. Key Countries/Regions Oligonucleotide Sales Value, (US$ Million), 2027–2032
Table 55. Key Countries/Regions Oligonucleotide Sales Volume, (MT), 2021–2026
Table 56. Key Countries/Regions Oligonucleotide Sales Volume, (MT), 2027–2032
Table 57. Abbott Molecular Company Information
Table 58. Abbott Molecular Introduction and Business Overview
Table 59. Abbott Molecular Oligonucleotide Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 60. Abbott Molecular Oligonucleotide Product Offerings
Table 61. Abbott Molecular Recent Developments
Table 62. PerkinElmer Company Information
Table 63. PerkinElmer Introduction and Business Overview
Table 64. PerkinElmer Oligonucleotide Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 65. PerkinElmer Oligonucleotide Product Offerings
Table 66. PerkinElmer Recent Developments
Table 67. SciGene Corporation Company Information
Table 68. SciGene Corporation Introduction and Business Overview
Table 69. SciGene Corporation Oligonucleotide Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 70. SciGene Corporation Oligonucleotide Product Offerings
Table 71. SciGene Corporation Recent Developments
Table 72. Roche NimbleGen Company Information
Table 73. Roche NimbleGen Introduction and Business Overview
Table 74. Roche NimbleGen Oligonucleotide Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 75. Roche NimbleGen Oligonucleotide Product Offerings
Table 76. Roche NimbleGen Recent Developments
Table 77. CytoTest Company Information
Table 78. CytoTest Introduction and Business Overview
Table 79. CytoTest Oligonucleotide Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 80. CytoTest Oligonucleotide Product Offerings
Table 81. CytoTest Recent Developments
Table 82. Oligo Factory Company Information
Table 83. Oligo Factory Introduction and Business Overview
Table 84. Oligo Factory Oligonucleotide Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 85. Oligo Factory Oligonucleotide Product Offerings
Table 86. Oligo Factory Recent Developments
Table 87. Danaher Company Information
Table 88. Danaher Introduction and Business Overview
Table 89. Danaher Oligonucleotide Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 90. Danaher Oligonucleotide Product Offerings
Table 91. Danaher Recent Developments
Table 92. Thermo Fisher Scientific Company Information
Table 93. Thermo Fisher Scientific Introduction and Business Overview
Table 94. Thermo Fisher Scientific Oligonucleotide Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 95. Thermo Fisher Scientific Oligonucleotide Product Offerings
Table 96. Thermo Fisher Scientific Recent Developments
Table 97. GE Company Information
Table 98. GE Introduction and Business Overview
Table 99. GE Oligonucleotide Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 100. GE Oligonucleotide Product Offerings
Table 101. GE Recent Developments
Table 102. Merck Company Information
Table 103. Merck Introduction and Business Overview
Table 104. Merck Oligonucleotide Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 105. Merck Oligonucleotide Product Offerings
Table 106. Merck Recent Developments
Table 107. Eurofins Scientific Company Information
Table 108. Eurofins Scientific Introduction and Business Overview
Table 109. Eurofins Scientific Oligonucleotide Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 110. Eurofins Scientific Oligonucleotide Product Offerings
Table 111. Eurofins Scientific Recent Developments
Table 112. Agilent Company Information
Table 113. Agilent Introduction and Business Overview
Table 114. Agilent Oligonucleotide Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 115. Agilent Oligonucleotide Product Offerings
Table 116. Agilent Recent Developments
Table 117. SUMITOMO CHEMICAL Company Information
Table 118. SUMITOMO CHEMICAL Introduction and Business Overview
Table 119. SUMITOMO CHEMICAL Oligonucleotide Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 120. SUMITOMO CHEMICAL Oligonucleotide Product Offerings
Table 121. SUMITOMO CHEMICAL Recent Developments
Table 122. Bachem Company Information
Table 123. Bachem Introduction and Business Overview
Table 124. Bachem Oligonucleotide Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 125. Bachem Oligonucleotide Product Offerings
Table 126. Bachem Recent Developments
Table 127. Sylentis Company Information
Table 128. Sylentis Introduction and Business Overview
Table 129. Sylentis Oligonucleotide Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 130. Sylentis Oligonucleotide Product Offerings
Table 131. Sylentis Recent Developments
Table 132. Key Raw Materials Lists
Table 133. Key Suppliers of Raw Materials Lists
Table 134. Oligonucleotide Downstream Customers
Table 135. Oligonucleotide Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Oligonucleotide Product Picture
Figure 2. Global Oligonucleotide Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Oligonucleotide Sales Value (US$ Million), 2021–2032
Figure 4. Global Oligonucleotide Sales Volume (MT), 2021–2032
Figure 5. Global Oligonucleotide Sales Price (USD/MT), 2021–2032
Figure 6. Oligonucleotide Report Years Considered
Figure 7. Global Oligonucleotide Players Revenue Ranking (US$ Million), 2025
Figure 8. Global Oligonucleotide Sales Volume Ranking of Players (MT), 2025
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Oligonucleotide Revenue in 2025
Figure 10. Oligonucleotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 11. DNA Picture
Figure 12. RNA Picture
Figure 13. Global Oligonucleotide Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Oligonucleotide Sales Value Market Share by Type, 2025 & 2032
Figure 15. Global Oligonucleotide Sales Volume by Type (MT), 2021 vs 2025 vs 2032
Figure 16. Global Oligonucleotide Sales Volume Market Share by Type, 2025 & 2032
Figure 17. Global Oligonucleotide Price by Type (USD/MT), 2021–2032
Figure 18. Product Picture of Gene Chip
Figure 19. Product Picture of Electrophoresis
Figure 20. Product Picture of Fluorescence In Situ Hybridization
Figure 21. Global Oligonucleotide Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 22. Global Oligonucleotide Sales Value Market Share by Application, 2025 & 2032
Figure 23. Global Oligonucleotide Sales Volume by Application (MT), 2021 vs 2025 vs 2032
Figure 24. Global Oligonucleotide Sales Volume Market Share by Application, 2025 & 2032
Figure 25. Global Oligonucleotide Price by Application (USD/MT), 2021–2032
Figure 26. North America Oligonucleotide Sales Value (US$ Million), 2021–2032
Figure 27. North America Oligonucleotide Sales Value by Country (%), 2025 vs 2032
Figure 28. Europe Oligonucleotide Sales Value (US$ Million), 2021–2032
Figure 29. Europe Oligonucleotide Sales Value by Country (%), 2025 vs 2032
Figure 30. Asia Pacific Oligonucleotide Sales Value (US$ Million), 2021–2032
Figure 31. Asia Pacific Oligonucleotide Sales Value by Region (%), 2025 vs 2032
Figure 32. South America Oligonucleotide Sales Value (US$ Million), 2021–2032
Figure 33. South America Oligonucleotide Sales Value by Country (%), 2025 vs 2032
Figure 34. Middle East & Africa Oligonucleotide Sales Value (US$ Million), 2021–2032
Figure 35. Middle East & Africa Oligonucleotide Sales Value by Country (%), 2025 vs 2032
Figure 36. Key Countries/Regions Oligonucleotide Sales Value (%), 2021–2032
Figure 37. Key Countries/Regions Oligonucleotide Sales Volume (%), 2021–2032
Figure 38. United States Oligonucleotide Sales Value (US$ Million), 2021–2032
Figure 39. United States Oligonucleotide Sales Value by Type (%), 2025 vs 2032
Figure 40. United States Oligonucleotide Sales Value by Application (%), 2025 vs 2032
Figure 41. Europe Oligonucleotide Sales Value (US$ Million), 2021–2032
Figure 42. Europe Oligonucleotide Sales Value by Type (%), 2025 vs 2032
Figure 43. Europe Oligonucleotide Sales Value by Application (%), 2025 vs 2032
Figure 44. China Oligonucleotide Sales Value (US$ Million), 2021–2032
Figure 45. China Oligonucleotide Sales Value by Type (%), 2025 vs 2032
Figure 46. China Oligonucleotide Sales Value by Application (%), 2025 vs 2032
Figure 47. Japan Oligonucleotide Sales Value (US$ Million), 2021–2032
Figure 48. Japan Oligonucleotide Sales Value by Type (%), 2025 vs 2032
Figure 49. Japan Oligonucleotide Sales Value by Application (%), 2025 vs 2032
Figure 50. South Korea Oligonucleotide Sales Value (US$ Million), 2021–2032
Figure 51. South Korea Oligonucleotide Sales Value by Type (%), 2025 vs 2032
Figure 52. South Korea Oligonucleotide Sales Value by Application (%), 2025 vs 2032
Figure 53. Southeast Asia Oligonucleotide Sales Value (US$ Million), 2021–2032
Figure 54. Southeast Asia Oligonucleotide Sales Value by Type (%), 2025 vs 2032
Figure 55. Southeast Asia Oligonucleotide Sales Value by Application (%), 2025 vs 2032
Figure 56. India Oligonucleotide Sales Value (US$ Million), 2021–2032
Figure 57. India Oligonucleotide Sales Value by Type (%), 2025 vs 2032
Figure 58. India Oligonucleotide Sales Value by Application (%), 2025 vs 2032
Figure 59. Oligonucleotide Industrial Chain
Figure 60. Oligonucleotide Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 10.1% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What was the global market size of Oligonucleotide in 2026?
What is the annual compound growth rate of the global Oligonucleotide market size from 2026 to 2032?
What was the global market size of Oligonucleotide in 2032?
Which companies rank high in the global Oligonucleotide market?
Related Reports
Global Oligonucleotide Market Research Report 2026
The global Oligonucleotide market was valued at US$ 1666 million in 2025 and is anticipated to reach US$ 3237 million by 2032, at a CAGR of 10.1% from 2026 to 2032.
Published Date: 2026-04-27
Pages: 137
USD 2900.00
(Single User License)
Global Oligonucleotide Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Oligonucleotide market is projected to grow from US$ 1527 million in 2024 to US$ 2967 million by 2031, at a CAGR of 10.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 151
USD 4900.00
(Single User License)
Global Oligonucleotide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Oligonucleotide market size was US$ 1527 million in 2024 and is forecast to a readjusted size of US$ 2967 million by 2031 with a CAGR of 10.1% during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 92
USD 4250.00
(Single User License)
Oligonucleotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Oligonucleotide was estimated to be worth US$ 1527 million in 2024 and is forecast to a readjusted size of US$ 2967 million by 2031 with a CAGR of 10.1% during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 114
USD 3950.00
(Single User License)
Global Oligonucleotide Market Research Report 2025
The global market for Oligonucleotide was valued at US$ 1527 million in the year 2024 and is projected to reach a revised size of US$ 2967 million by 2031, growing at a CAGR of 10.1% during the forecast period.
Published Date: 2025-02-24
Pages: 101
USD 2900.00
(Single User License)
Oligonucleotide - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Published Date: 2024-01-16
Pages: 144
USD 3950.00
(Single User License)
Global Oligonucleotide Market Research Report 2024
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Published Date: 2024-01-04
Pages: 110
USD 2900.00
(Single User License)
Global Oligonucleotide Market Research Report 2026
The global Oligonucleotide market was valued at US$ 1666 million in 2025 and is anticipated to reach US$ 3237 million by 2032, at a CAGR of 10.1% from 2026 to 2032.
Published: 2026-04-27
Pages: 137
USD 2900.00 (Single User License)Global Oligonucleotide Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Oligonucleotide market is projected to grow from US$ 1527 million in 2024 to US$ 2967 million by 2031, at a CAGR of 10.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 151
USD 4900.00 (Single User License)Global Oligonucleotide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Oligonucleotide market size was US$ 1527 million in 2024 and is forecast to a readjusted size of US$ 2967 million by 2031 with a CAGR of 10.1% during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 92
USD 4250.00 (Single User License)Oligonucleotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Oligonucleotide was estimated to be worth US$ 1527 million in 2024 and is forecast to a readjusted size of US$ 2967 million by 2031 with a CAGR of 10.1% during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 114
USD 3950.00 (Single User License)Global Oligonucleotide Market Research Report 2025
The global market for Oligonucleotide was valued at US$ 1527 million in the year 2024 and is projected to reach a revised size of US$ 2967 million by 2031, growing at a CAGR of 10.1% during the forecast period.
Published: 2025-02-24
Pages: 101
USD 2900.00 (Single User License)Oligonucleotide - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Published: 2024-01-16
Pages: 144
USD 3950.00 (Single User License)Global Oligonucleotide Market Research Report 2024
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Published: 2024-01-04
Pages: 110
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now